Literature DB >> 26163748

Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.

Weiwei Cao1, Jianwen Chen2, Yanfang Chen3, Shaorui Chen2, Xi Chen2, Heqing Huang4, Peiqing Liu5.   

Abstract

BACKGROUND AND AIMS: It is commonly believed that diabetes is an important contributor to heart failure (HF) development. However, the detail effect of diabetogenesis on HF is controversy: both beneficial and harmful roles were reported. In the present study, we aim to explore the unambiguous action of diabetes on chronic HF progression and the underlying mechanism.
METHODS: Diabetes and myocardial infarction (MI) were induced by streptozotocin (STZ) injection and left-sided thoracotomy and left anterior descending coronary artery (LAD) ligation, respectively. Pyridoxamine was used as the antagonist of advanced glycation end products (AGEs). Adult male SD rats were assigned to 5 groups: Sham; MI; Diabetes (D); Diabetes+MI (DMI) and DMI+pyridoxamine (DMI+P). Animals were sacrificed at the end of 12weeks. The comparison of LV myocardium was made between border zone from MI or DMI animals and control LV tissues from sham-operated animals. Cardiomyocytes and dendritic cells were prepared from the Sprague-Dawley rats and cocultured in the presence or absence of AGEs.
RESULTS: DMI group showed highest level of AGEs and inflammatory markers, which were significantly reduced in the presence of pyridoxamine. In vitro experiment disclosed AGEs could stimulate DCs differentiation and promote cytokines production, finally upregulated hypertrophy-related genes expression in cardiocytes. Intervention DCs differentiation was sufficient to improve cardiocytes morphology.
CONCLUSION: Our results clearly demonstrate that diabetes would promote chronic HF progression at least in part through stimulating DCs differentiation and series downstream inflammatory responses induced by AGEs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation end product; Dendritic cells; Heart failure; NF-κB signaling

Mesh:

Substances:

Year:  2015        PMID: 26163748     DOI: 10.1016/j.abb.2015.07.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.

Authors:  Henry H Ruiz; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

2.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14

3.  Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction.

Authors:  Bianca de Moraes Fracasso; Juliana Oliveira Rangel; Alessandra Gonçalves Machado; Fernanda Severo Curuja; Amanda Lopes; Virgílio Olsen; Nadine Clausell; Andreia Biolo; Luis Eduardo Rohde; Michael Andrades
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

Review 4.  A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair.

Authors:  Kang Sun; Yi-Yuan Li; Jin Jin
Journal:  Signal Transduct Target Ther       Date:  2021-02-22

5.  Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ1 signaling pathway in diabetic atherosclerosis.

Authors:  Liding Zhao; Ya Li; Tian Xu; Qingbo Lv; Xukun Bi; Xianglan Liu; Guosheng Fu; Yunzeng Zou; Junbo Ge; Zhaoyang Chen; Wenbin Zhang
Journal:  Mol Med       Date:  2022-01-21       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.